UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

1423 POSTER Polymorphism Analysis in the AVADO Randomised Phase III Trial of First-line Bevacizumab (BEV) Combined With Docetaxel in HER2-negative Metastatic Breast Cancer (mBC)

European journal of cancer (1990), 2011, Vol.47, p.S176-S176

2011

Link zum Volltext

Verfügbarkeit prüfen

803 ORAL Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)

European journal of cancer (1990), 2011, Vol.47, p.S95-S96

2011

Link zum Volltext

Verfügbarkeit prüfen

1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension

European journal of cancer (1990), 2011, Vol.47, p.S172-S173

2011

Link zum Volltext

Verfügbarkeit prüfen

804 ORAL Evaluation of Plasma VEGFA as a Potential Predictive Pan-tumour Biomarker for Bevacizumab

European journal of cancer (1990), 2011, Vol.47, p.S96-S96

2011

Link zum Volltext

Verfügbarkeit prüfen

1415 POSTER Blood Plasma VEGFA Analysis in the AVAGAST Randomized Study of First-line Bevacizumab (bev) + Capecitabine/Cisplatin (cape/cis) in Patients (pts) With Advanced Gastric Cancer (AGC)

European journal of cancer (1990), 2011, Vol.47, p.S173-S174

2011

Link zum Volltext

Verfügbarkeit prüfen

1414 POSTER Single Nucleotide Polymorphism Analysis and Outcome in Advanced-stage Cancer Patients Treated With Bevacizumab

European journal of cancer (1990), 2011, Vol.47, p.S173-S173

2011

Link zum Volltext

Verfügbarkeit prüfen

Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors

Annals of oncology, 2017-11, Vol.28 (11), p.2882-2887

2017

Link zum Volltext

Verfügbarkeit prüfen

Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib

Annals of oncology, 2017-08, Vol.28 (8), p.2021-2024

2017

Link zum Volltext

Verfügbarkeit prüfen

Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials

Annals of oncology, 2015-12, Vol.26 (12), p.2450-2456

2015

Link zum Volltext

Verfügbarkeit prüfen

11P Pharmacokinetic/pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Annals of oncology, 2020-03, Vol.31, p.S3

2020

Link zum Volltext

Verfügbarkeit prüfen

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer

The pharmacogenomics journal, 2015-02, Vol.15 (1), p.69-76

2015

Link zum Volltext

Verfügbarkeit prüfen

221 DISCUSSION 89Zr-bevacizumab PET imaging in renal cell carcinoma patients: feasibility of tumor VEGF quantification

European journal of cancer supplements, 2010, Vol.8 (7), p.72-73

2010

Link zum Volltext

Verfügbarkeit prüfen

Tumour Biomarker and Plasma Time Course Data from Abigail, A Phase II Study of 1st-Line Bevacizumab + Chemotherapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix405

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Genotyping and Efficacy Outcomes: Exploratory Biomarker Data from the Phase II Abigail Study of 1st-Line Bevacizumab + Chemotherapy in Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix406

2012

Link zum Volltext

Verfügbarkeit prüfen

1657P - Biomarker (BM) Results from the Phase III Averel Trial of 1st-Line Bevacizumab (BV), Trastuzumab (H) + Docetaxel (T) for HER2-Positive Locally Recurrent/Metastatic Breast Cancer (LR/MBC)

Annals of oncology, 2012-09, Vol.23, p.ix531-ix532

2012

Link zum Volltext

Verfügbarkeit prüfen

Biomarker (BM) Results from the Phase III Averel Trial of 1st-Line Bevacizumab (BV), Trastuzumab (H) + Docetaxel (T) for HER2-Positive Locally Recurrent/Metastatic Breast Cancer (LR/MBC)

Annals of oncology, 2012-09, Vol.23, p.ix531-ix532

2012

Link zum Volltext

Verfügbarkeit prüfen

198P - Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)

Annals of oncology, 2012-09, Vol.23, p.ix81-ix82

2012

Link zum Volltext

Verfügbarkeit prüfen

Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)

Annals of oncology, 2012-09, Vol.23, p.ix81-ix82

2012

Link zum Volltext

Verfügbarkeit prüfen

1194P - Tissue and Serum Biomarker Results from the Phase II Innovations Study in Non-Small Cell Lung Cancer (NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix390-ix390

2012

Link zum Volltext

Verfügbarkeit prüfen

Tissue and Serum Biomarker Results from the Phase II Innovations Study in Non-Small Cell Lung Cancer (NSCLC)

Annals of oncology, 2012-09, Vol.23, p.ix390

2012

Link zum Volltext

Verfügbarkeit prüfen

Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition

Biochemical Society transactions, 2005-08, Vol.33 (Pt 4), p.689

2005

Link zum Volltext

Verfügbarkeit prüfen

1[alpha],25-dihydroxyvitamin D3 enhances annexin II dependent proliferation of osteoblasts

Journal of cellular biochemistry, 2007-02, Vol.100 (3), p.679-692

2007

Link zum Volltext

Verfügbarkeit prüfen

1[alpha],25‐dihydroxyvitamin D 3 enhances annexin II dependent proliferation of osteoblasts

Journal of cellular biochemistry, 2007-02, Vol.100 (3), p.679-692

2007

Link zum Volltext

Verfügbarkeit prüfen

Disposition of cyromazine in plants under environmental conditions

Journal of agricultural and food chemistry, 1990-03, Vol.38 (3), p.860-864

1990

Link zum Volltext

Verfügbarkeit prüfen

A simplified high-performance liquid chromatographic residue procedure for the determination of glyphosate herbicide and (aminomethyl)phosphonic acid in fruits and vegetables employing postcolumn fluorogenic labeling

Journal of agricultural and food chemistry, 1983-01, Vol.31 (1), p.69-72

1983

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(49)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(22)
Humans
(9)
Animals
(7)
Biological And Medical Sciences
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Hematology, Oncology And Palliative Medicine
(7)
Male
(7)
Adult
(5)
Female
(5)
Chemistry
(4)
Food Science & Technology
(4)
Microbiology
(4)
Physical Sciences
(4)
Agriculture
(3)
Agriculture, Multidisciplinary
(3)
Baclofen
(3)
Chemistry, Applied
(3)
Colorectal Cancer
(3)
Genes
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1423 POSTER Polymorphism Analysis in the AVADO Randomised Phase III Trial of First-line Bevacizumab (BEV) Combined With Docetaxel in HER2-negative Metastatic Breast Cancer (mBC)

803 ORAL Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)

1412 POSTER Genetic Markers in Relation to Bevacizumab-induced Hypertension

804 ORAL Evaluation of Plasma VEGFA as a Potential Predictive Pan-tumour Biomarker for Bevacizumab

1415 POSTER Blood Plasma VEGFA Analysis in the AVAGAST Randomized Study of First-line Bevacizumab (bev) + Capecitabine/Cisplatin (cape/cis) in Patients (pts) With Advanced Gastric Cancer (AGC)

1414 POSTER Single Nucleotide Polymorphism Analysis and Outcome in Advanced-stage Cancer Patients Treated With Bevacizumab

Circulating tumor DNA as a novel tool to shape clinical trial designs with the potential to impact outcomes: a focus on PI3K inhibitors

Discovery and development of novel therapies in advanced breast cancer: rapid development of ribociclib

Variations in genes regulating tumor-associated macrophages (TAMs) to predict outcomes of bevacizumab-based treatment in patients with metastatic colorectal cancer: results from TRIBE and FIRE3 trials

11P Pharmacokinetic/pharmacodynamic (PK/PD) exposure-response characterization of GSK3359609 (GSK609) from INDUCE-1, a phase I open-label study

Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer

221 DISCUSSION 89Zr-bevacizumab PET imaging in renal cell carcinoma patients: feasibility of tumor VEGF quantification

Tumour Biomarker and Plasma Time Course Data from Abigail, A Phase II Study of 1st-Line Bevacizumab + Chemotherapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)

Clinical Genotyping and Efficacy Outcomes: Exploratory Biomarker Data from the Phase II Abigail Study of 1st-Line Bevacizumab + Chemotherapy in Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)

1657P - Biomarker (BM) Results from the Phase III Averel Trial of 1st-Line Bevacizumab (BV), Trastuzumab (H) + Docetaxel (T) for HER2-Positive Locally Recurrent/Metastatic Breast Cancer (LR/MBC)

Biomarker (BM) Results from the Phase III Averel Trial of 1st-Line Bevacizumab (BV), Trastuzumab (H) + Docetaxel (T) for HER2-Positive Locally Recurrent/Metastatic Breast Cancer (LR/MBC)

198P - Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)

Biomarker (BM) Results from GOG-0218, a Phase 3 Trial of Front-Line Bevacizumab (BV) + Chemotherapy (CT) for Ovarian Cancer (OC)

1194P - Tissue and Serum Biomarker Results from the Phase II Innovations Study in Non-Small Cell Lung Cancer (NSCLC)

Tissue and Serum Biomarker Results from the Phase II Innovations Study in Non-Small Cell Lung Cancer (NSCLC)

Functional consequences of DNA mismatch repair missense mutations in murine models and their impact on cancer predisposition

1[alpha],25-dihydroxyvitamin D3 enhances annexin II dependent proliferation of osteoblasts

1[alpha],25‐dihydroxyvitamin D 3 enhances annexin II dependent proliferation of osteoblasts

Disposition of cyromazine in plants under environmental conditions

A simplified high-performance liquid chromatographic residue procedure for the determination of glyphosate herbicide and (aminomethyl)phosphonic acid in fruits and vegetables employing postcolumn fluorogenic labeling

Suchergebnisse filtern